InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,478.76
(
0.02%
)
US TECH 100
19,266.40
(
0.27%
)
Dow Jones
39,224.42
(
0.25%
)
Brent Oil
85.11
(
0.75%
)
Bitcoin
61,794.25
(
1.61%
)
Post# of 319093
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

wkpeters

Send PM Follow Ignore
Followers 2
Posts 80
Boards Moderated 0
Alias Born 07/26/2010

wkpeters

Re: None

Tuesday, 07/27/2010 1:13:11 PM

Tuesday, July 27, 2010 1:13:11 PM

Post# of 319093
Amazing breakthrough for cancer patients in The USA!

insert-text-here

MuGard, a FDA-approved, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis and stomatitis, is now being introduced to Centers of Excellence, Key Opinion Leaders, cancer research centers and selected physicians in the United States.

Access Pharmaceuticals, Inc. (OTC Bulletin Board:ACCP.ob - News), a biopharmaceutical company specializing in products for cancer and supportive care, today announced its e-marketing partner, iMedicor (OTC Bulletin Board:VMCI.ob - News) commenced the initial phase of a multi-channel marketing program for MuGard.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up